Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print April 28, 2008
DOI: 10.2337/db07-0763

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Austin, R. L
Right arrow Articles by Krook, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Austin, R. L
Right arrow Articles by Krook, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

siRNA-Mediated Reduction of IKKβ Prevents TNF-{alpha}-Induced Insulin Resistance in Human Skeletal Muscle

Reginald L Austin1, Anna Rune1, Karim Bouzakri1, Juleen R. Zierath1, and Anna Krook1,,2

1Department of Molecular Medicine and Surgery, and Department of Physiology and
2Pharmacology, Karolinska Institutet S-171 77 Stockholm

Objective: Pro-inflammatory cytokines contribute to systemic low-grade inflammation and insulin resistance. Tumor necrosis factor-alpha (TNF-{alpha}) impedes insulin signaling in insulin target tissues. We determined the role of IKKβ in TNF-{alpha}-induced impairments in insulin signaling and glucose metabolism in skeletal muscle.

Research Design and Methods: Small interfering RNA (siRNA) was used to silence IKKβ gene expression in primary human skeletal muscle myotubes from non-diabetic subjects. siRNA gene silencing reduced IKKβ protein expression 73% (p<0.05). Myotubes were incubated in the absence or presence of insulin and/or TNF-{alpha} and effects of IKKβ silencing were determined on insulin signaling and glucose metabolism.

Results: Insulin increased glucose uptake 1.7-fold (p<0.05), and glucose incorporation into glycogen 3.8-fold (p<0.05) in myotubes from non-diabetic subjects. TNF-{alpha} exposure fully impaired insulin-mediated glucose uptake and metabolism. IKKβ siRNA protected against TNF-{alpha}-induced impairments in glucose metabolism, since insulin-induced increases in glucose uptake uptake (1.5-fold, p<0.05) and glycogen synthesis (3.5-fold, p<0.05) were restored. Conversely, TNF-{alpha}-induced increases in insulin receptor substrate-1 (IRS-1) serine phosphorylation (Ser312), JNK or ERK-1/2 MAPK phosphorylation were unaltered by siRNA-mediated IKKβ reduction. siRNA-mediated IKKβ reduction also prevented TNF-{alpha}-induced insulin resistance on Akt Ser473 and Thr308 phosphorylation and phosphorylation of the 160kDa Akt substrate AS160. IKKβ silencing was without effect on cell differentiation. Finally, mRNA expression of GLUT1, GLUT4, or protein expression of mitogenic-activated protein kinase kinase kinase kinase isoform 4 (MAP4K4) was unaltered by IKKβ siRNA.

Conclusion: IKKβ silencing prevents TNF-{alpha}-induced impairments in insulin action on Akt phosphorylation and glucose uptake and metabolism in human skeletal muscle.


Correspondence: Anna.Krook{at}ki.se

Key Words: Human Skeletal Muscle • Cell Culture • Insulin Resistance • Tumor Necrosis Factor Alpha • I{kappa}B Kinase Beta


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.